Lam Research Corp. filings document regulatory disclosures for a semiconductor wafer fabrication equipment company. Its Form 8-K reports include operating results and financial-condition updates, material-event disclosures, exhibits for quarterly earnings releases, governance matters, capital-structure items, and changes affecting security-holder rights.
Lam Research proxy and related filings cover annual meeting proposals, director elections, executive compensation advisory votes, stock incentive plan approvals, auditor ratification, charter amendments, stockholder proposals, and changes in the company’s independent registered public accounting firm.
Lam Research Corporation (LRCX) is asking stockholders to elect 10 director nominees and vote at its virtual annual meeting on November 3, 2026, at 9:30 a.m. Pacific Time. The Board recommends voting FOR each nominee, executive compensation and ratification of KPMG LLP for fiscal 2027, and AGAINST the stockholder proposal if properly presented.
Sohail U. Ahmed and Michael R. Cannon will retire effective November 2, 2026, and are not standing for re-election; the Board will then have 10 directors. More than 90% of the annual incentive program is tied to company financial, strategic and operational performance metrics, and the long-term incentive program uses a three-year performance period. For calendar 2025, 53.8% of suppliers measured by emissions had set science-based targets, exceeding the 46.5% goal; 35.1% of customers measured by emissions had set targets, below the 83% goal. Management will not provide a business update at the meeting.
LAM RESEARCH CORP (LRCX) reported that President and CEO Timothy Archer exercised employee stock options for 30,000 shares of common stock on September 9, 2026 at an exercise price of $30.033 per share and sold 30,000 shares of common stock at $319.26 per share the same day. The option exercise reduced his option position to 31,400 options, and the sale and related transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026. Archer also reports indirect holdings of common stock through his 401(k) plan and his spouse’s 401(k) plan.
LAM RESEARCH CORP (LRCX) director Bethany Mayer reported selling 9,557 sharesSeptember 9, 2026weighted average price of $314.74 per share$314.08 and $314.99 per share. After these transactions, the trust held 20,995 shares1,635 shares
LAM RESEARCH CORP (LRCX) discloses a planned sale of its common stock under Rule 144 for the account of Bethany Mayer, a director, with the Jantzen/Mayer Family 2002 Trust as seller and Bethany Mayer as trustee. The notice covers 9,557 shares of common stock, with an aggregate market value of $3,007,970.18, planned for sale on September 9, 2026 through UBS Financial Services Inc. The shares relate to multiple prior RSU vesting events between October 31, 2021 and October 31, 2025.
LAM RESEARCH CORP (LRCX) has a planned sale of restricted securities by Timothy M. Archer under Rule 144. The notice covers the proposed sale of 30,000 shares of common stock through Fidelity Brokerage Services LLC, expected around September 9, 2026, in connection with a stock option exercise. Archer also reported Rule 144 sales of 30,000 shares on July 2, 2026 and 30,000 shares on August 6, 2026.
LAM RESEARCH CORP (LRCX) senior vice president Varadarajan Seshasayee reported option exercises and related stock sales on September 2, 2026. He exercised employee stock options for 39,750 shares of common stock at exercise prices of $59.881 and $30.033 per share, and sold a total of 59,750 shares of common stock at $291.32 per share pursuant to a Rule 10b5-1 trading plan adopted on May 4, 2026. He also reports indirect ownership of 2,366.911 shares of common stock through a 401(k) plan, and a footnote states that his reported holdings include shares underlying unvested restricted stock units.
LAM RESEARCH CORP (LRCX) received a notice that officer Varadarajan Seshasayee plans to sell up to 59,750 shares of common stock under Rule 144 through Fidelity Brokerage Services LLC. The filing lists an approximate sale date of September 2, 2026 and an aggregate market value of about $17,406,370. The shares derive from 20,000 restricted stock units vesting on March 1, 2026 and 39,750 shares from a stock option exercise on September 2, 2026.
LAM RESEARCH CORP (LRCX) reported an insider transaction by Chief Legal Officer Ava Harter. On August 31, 2026, Harter sold 5,000 shares of common stock at $302.46 per share in an open market or private transaction pursuant to a Rule 10b5-1 trading plan adopted on April 28, 2026. Following this sale, Harter directly holds 42,462.455 shares of Lam Research common stock, and this amount includes shares subject to unvested restricted stock units.
LAM RESEARCH CORP (LRCX) has a notice of proposed sale under Rule 144 for common stock held for the account of officer Ava Harter. The filing indicates a plan to sell 5,000 shares of common stock, originating from restricted stock vesting on 08/05/2026, with Fidelity Brokerage Services LLC acting as broker.